Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Summary of Post-Operative Therapy: Part 2 of Lecture from Cancer Lifeline
Author
Howard (Jack) West, MD

This slide presentation is the second part of a lecture I gave at the Seattle-based non-profit Cancer Lifeline a few months ago. This covers the evidence supporting post-operative (adjuvant) chemotherapy for patients with early stage NSCLC, the need to recognize that this does not apply to all patients who have undergone surgery, and the emerging clinical research and ongoing trials that may lead to improvements in our cure rate for early stage NSCLC patients in the future.

Here is the presentation in video format, the audio version, transcript, and a pdf file of the figures. I hope it's helpful.

[powerpress]

Cancer Lifeline Part 2 Adjuvant Therapy Early Stage NSCLC Audio Podcast

cancer-lifeline-part-2-adjuvant-therapy-early-stage-nsclc-transcript

cancer-lifeline-part-2-adjuvant-therapy-early-stage-nsclc-figures

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora